D induce hepatotoxicity involving oxidative harm and inflammatory response.BioMed Investigation

D induce hepatotoxicity involving oxidative harm and inflammatory response.BioMed Analysis Internationaloxygen species,” Environmental Science and Technology, vol. 45, no. four, pp. 1638644, 2011. X. M. Zheng, H. L. Liu, W. Shi, S. Wei, J. P. Giesy, and H. X. Yu, “Effects of perfluorinated compounds on development of zebrafish embryos,” Environmental Science and Pollution Analysis, vol. 19, no. 7, pp. 2498505, 2012. M. R. Qazi, B. D. Nelson, J. W. DePierre, and M. AbediValugerdi, “High-dose dietary exposure of mice to perfluorooctanoate or perfluorooctane sulfonate exerts toxic effects on myeloid and B-lymphoid cells inside the bone marrow and these effects are partially dependent on lowered meals consumption,” Food and Chemical Toxicology, vol. 50, no. 9, pp. 2955963, 2012. X. Yao and L. Zhong, “Genotoxic danger and oxidative DNA harm in HepG2 cells exposed to perfluorooctanoic acid,” Mutation Study, vol. 587, no. 1-2, pp. 384, 2005. S. D. Geiger, J. Xiao, along with a. Shankar, “Positive association among perfluoroalkyl chemical compounds and hyperuricemia in children,” The American Journal of Epidemiology, vol. 177, no. 11, pp. 1255262, 2013. A. Shankar, J. Xiao, as well as a. Ducatman, “Perfluorooctanoic acid and cardiovascular disease in US adults,” Archives of Internal Medicine, vol. 172, no. 18, pp. 1397403, 2012. A. Shankar, J. Xiao, and a. Ducatman, “Perfluoroalkyl chemical compounds and chronic kidney disease in US Adults,” The American Journal of Epidemiology, vol. 174, no. eight, pp. 89300, 2011. D. Melzer, N. Rice, M. H. Depledge, W. E. Henley, and T. S. Galloway, “Association involving serum perfluorooctanoic acid (PFOA) and thyroid disease within the U.S. National Health and Nutrition Examination Survey,” Environmental Well being Perspectives, vol. 118, no. five, pp. 68692, 2010. V. Gallo, G. Leonardi, B. Genser et al., “Serum perfluorooctanoate (PFOA) and perfluorooctane sulfonate (PFOS) concentrations and liver function biomarkers inside a population with elevated PFOA exposure,” Environmental Health Perspectives, vol. 120, no. five, pp. 65560, 2012. N. Kudo and Y. Kawashima, “Toxicity and toxicokinetics of perfluorooctanoic acid in humans and animals,” Journal of Toxicological Sciences, vol. 28, no. two, pp. 497, 2003. L. Cui, Q.-F. Zhou, C.-Y. Liao, J.-J. Fu, and G.-B. Jiang, “Studies around the toxicological effects of PFOA and PFOS on rats applying histological observation and chemical evaluation,” Archives of Environmental Contamination and Toxicology, vol.Amygdalin 56, no.Metronidazole two, pp.PMID:24257686 33849, 2009. L. M. Eldasher, X. Wen, M. S. Tiny, K. M. Bircsak, L. L. Yacovino, and L. M. Aleksunes, “Hepatic and renal Bcrp transporter expression in mice treated with perfluorooctanoic acid,” Toxicology, vol. 306, no. four, pp. 10813, 2013. A. G. Abdellatif, V. Preat, H. S. Taper, and M. Roberfroid, “The modulation of rat liver carcinogenesis by perfluorooctanoic acid, a peroxisome proliferator,” Toxicology and Applied Pharmacology, vol. 111, no. three, pp. 53037, 1991. V. Bindhumol, K. C. Chitra, and P. P. Mathur, “Bisphenol A induces reactive oxygen species generation within the liver of male rats,” Toxicology, vol. 188, no. 2-3, pp. 11724, 2003. D. Bagchi, J. Balmoori, M. Bagchi, X. Ye, C. B. Williams, and S. J. Stohs, “Comparative effects of TCDD, endrin, naphthalene and chromium (VI) on oxidative stress and tissue harm in the liver and brain tissues of mice,” Toxicology, vol. 175, no. 1, pp. 732, 2002. A. P. Senft, T. P. Dalton, D. W. Nebert, M. B. Genter, R. J. Hutchinson, and H. G. Shertzer, “Dioxin increases re.